Quantifying Adaptive and Innate Immune Responses in HIV-Infected Participants Using a Novel High Throughput Assay.
Yong MK, Cameron PU, Spelman T, Elliott JH, Fairley CK, Boyle J, Miyamasu M, Lewin SR
Risk factors for unstructured treatment interruptions and association with survival in low to middle income countries.
McMahon JH, Spelman T, Ford N, Greig J, Mesic A, Ssonko C, Casas EC, O'Brien DP
Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort.
Doyle JS, Grebely J, Spelman T, Alavi M, Matthews GV, Thompson AJ, Dore GJ, Hellard ME, ATAHC Study Group
A 'test and treat' prevention strategy in Australia requires innovative HIV testing models: a cohort study of repeat testing among 'high-risk' men who have sex with men.
Wilkinson AL, El-Hayek C, Spelman T, Fairley CK, Leslie D, McBryde ES, Hellard M, Stoové M
Therapeutic Potential of Tea Tree Oil for Scabies.
Thomas J, Carson CF, Peterson GM, Walton SF, Hammer KA, Naunton M, Davey RC, Spelman T, Dettwiller P, Kyle G, Cooper GM, Baby KE
Risk factors for mortality during antiretroviral therapy in older populations in resource-limited settings.
O'Brien D, Spelman T, Greig J, McMahon J, Ssonko C, Casas E, Mesic A, Du Cros P, Ford N